Outsourcing of pharmaceutical development has become a daily topic in the Life Science Industry within the last years. Outsourcing represents an effective and costefficient way of developing new products for companies with no or limited in-house capacities. Pharmaceutical and biotech companies increasingly outsource research, development and manufacturing, and engage consultants for support in regulatory and quality assurance questions.

Target group: SME’s active in drug discovery and development.

Further information and registration on: www.swissbiotech.org/registration/regulatory